Industry Research Reports: Biopharmaceutical

Showing posts with label Biopharmaceutical. Show all posts

Tuesday, 6 August 2013

Deep Research Report: Competitive Information Service Package Market Share 1-year subscription

Description

Subscription to this product provides access during one year to three Competitive Intelligence information products released by La Merie Publishing with great cost savings:

1) Flat-Rate Access to La Merie Publishing Reports:

Access during one year to all existing and new reports produced by La Merie Publishing and listed in the online store. Among La Merie Publishing reports are Competitor Analysis reports as well as Full Reports. La Merie Publishing reports are continuously updated and new ones released. Reports can be searched for and identified in La Merie Publishing’s online store. After purchase of the product, existing reports will be made available to the customer by e-mail delivery of the pdf reports. New reports will automatically be sent upon release of the report.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/competitive-information-service-package

Features of the Flat-Rate Access to La Merie Publishing Reports:

Dynamic content (more than 50 updates and new releases per year)
Convenient e-mail delivery of pdf reports upon subscription and new release
Broad coverage of Oncology, Biosimilars, Antibodies, Proteins and Vaccines
Great savings over individual purchases

2) R&D Drug Pipeline Database

Online access to more than 16,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mechanism of Action, Product Category, Therapeutic Area, indication and R&D Phase. Use of the R&D database of marketed and investigational drugs is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major products are provided. The projects can be segmented into Therapeutic Areas, Territories, Product Categories and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column headers, projects can be arranged and listed/displayed in ascending or descending alphabetical or numerical order, e.g. for R&D phase, product category or company name.

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172486

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Monday, 8 July 2013

Market Report: Array Biopharma Partnering Market Trends 2005-2013

The Partnering Agreements with Intermune 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Intermune and its partnering interests and activities over the past seven years.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/array-biopharma-partnering-2005-2013

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service.

This report provides all the information you require to better understand Intermune and its partnering interests and activities over the past seven years.

One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives.

The initial chapters of this report provide an orientation of bigpharma’s dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst

Chapter 2 lists the top 50 leading biopharma companies based on 2010 pharmaceutical revenues and their respective partnering activity.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/170690

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Wednesday, 26 June 2013

Recent Report: Competitor Analysis Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors

The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets:

Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA)
G-CSF & GM-CSF
Thrombopoietin & Thrombopoiesis Stimulating Agents
Interferon
Insulin
Coagulation Factors
Human Growth Hormone (hGH)
FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART)
Thrombolytics & Fibrinolytics
Enzyme Replacement Therapies

Territories covered are the major pharmaceutical markets North America, Europe and Japan, as well as South Korea, India, China and other countries in Latin America, Africa and Australasia.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/competitor-analysis-therapeutic-proteins-biosimilars-biobetters-and-biosuperiors

With more than US$ 50 bln in sales, therapeutic proteins represent a major category of pharmaceutical products with established therapeutic value and high economic attractiveness. As more and more of the branded products are running out of patent protection and regulatory agencies are providing better guidance, development of biosimilar versions as well as of improved next generation versions are a highly attractive goal for pharmaceutical and biotechnology as well as technology focused companies.

This report includes a compilation of current active projects in research and development of biosimilar and novel biobetter/biosuperior therapeutic proteins as well as non-protein based competitor products and an overview of approved products in regulated and less regulated markets. Competitor projects are listed in a tabular format providing Information on: